AsiaIntervention

Promising results with #MeRes100 bioresorbable scaffold: 98.84% success, 0% thrombosis, MI, or TLR at 12 months. A metal-free future for PCI? 📖asiaintervention.org/article/a-real… @APSIC6 @EuroInterventio @PCRonline

🚨 3-yr data: BioMime Morph SES shows 98.8% TLF-free survival, 0.24% ST, 0.5% mortality in very long lesions (50–60 mm). No overlaps. No IVUS. Strong real-world outcomes. 📄asiaintervention.org/article/long-t… @APSIC6 @EuroInterventio @PCRonline

Successful #percutaneousclosure of a perimembranous ventricular septal defect (pmVSD) in a 2-month-old infant using the #AmplatzerDuctOccluderII device. #PediatricCardiology 👉asiaintervention.org/article/percut… @APSIC6 @EuroInterventio @PCRonline

First #Cardiovalve tricuspid valve replacement in Asia! 🫀 A game-changer for high-risk #heartfailure patients. 👉 asiaintervention.org/article/transc… @APSIC6 @EuroInterventio @PCRonline

Next-day discharge after alternative access #TAVI? In this prospective study of 85 A-TAVI patients, NDD/48h discharge was safe with low 30-day readmission and zero mortality. Transapical access required longer stay, but ~50% discharged by day 2. @RodrigoBagur…

Even #BASILICA can’t always prevent coronary occlusion during #TAVI—especially with valve misalignment. A must-read case for structural heart teams. 🫀 👉 asiaintervention.org/article/commis… @APSIC6 @EuroInterventio @PCRonline

#ICI myocarditis, could we rechallenge?🫀 ⚠️#Multidisciplinary team discussion is 🔑key before deciding on rechallenge 🆚 permanent discontinuation Considerations include: 📍Clinical presentation: is it fulminant, non-fulminant, or asymptomatic? 📍Alternative cancer treatments…

🚨 A new heart valve system just passed its first human test! The Crea Valve showed strong results with no major complications. A big step forward for heart care! 🫀 #HeartHealth #MEDTECH @APSIC6 @EuroInterventio @PCRonline Read more: asiaintervention.org/article/initia…

80F with LMT/LAD blockage had #PCI. #OCT showed a Z-shaped catheter risking fracture. Using the newer #Opstardevice avoided this. Device design is crucial in #patientsafety. Read more here: asiaintervention.org/article/optica… @APSIC6 @EuroInterventio @PCRonline

At #EuroPCR, I sat down with @EuroInterventio EIC @DFCapodanno for @TCTMD's #OnRecord to chat about what it means to leave a legacy in cardiovascular medicine. tctmd.com/videos/on-reco…

61-year-old with recurrent stent blockage treated with #cuttingballoons and #drugelutingtech. #OCT showed success—and paclitaxel crystals. Symptom-free at 4 months! 💉🫀📈 #InterventionalCardiology Read the full article on AsiaIntervention: asiaintervention.org/article/paclit…

My learning points from #euroPCR 2025: #IC community interests are high in the coronary field despite growing of the structural field. Topics which surprised me in terms of assistance are vulnerable plaque, coronary thrombectomy, imaging, physiology and CHIP.this reflects the…

PCR Perspectives: how to manage treatment dilemmas in #STEMI patients with multivessel disease 📺pcronline.com/Cases-resource… Managing STEMI patients with MVD is a complex challenge evolving rapidly thanks to new clinical evidence. @McInerneyAngela , @DrNataliaP, and @MGtberg…

🚀 Steerable microcatheter aids complex CTO PCI in LCx with severe tortuosity. Game-changer for tough anatomies! 💡🫀 🔗 Full study: asiaintervention.org/article/recana… #PCI #CTO #Cardiology #Innovation #MedicalDevices #Intervention

It was a great pleasure being part of this outstanding event. Looking forward to next year’s #TCTPlusMiddleEast2026 @crfheart @TCT_ME_ Mark your 🗓️ @kalazizimd @mirvatalasnag @AlkashkariWail @drptca @jgranadacrf @mmamas1973 @djc795 @crfheart @AnasNomanMD @MusaSharkawiMD

#EuroPCR - PCR Perspectives: How to implement the diagnosis of #INOCA in everyday practice 📺pcronline.com/Cases-resource… @VijayKunadian and @JEscaned explore the real-world implementation of INOCA (#Ischemia with Non-Obstructive Coronary Arteries) and #ANOCA (Angina with…

Congratulations Prof @dukwoo_park !!! It is one of the most talk about study. This award prove that. Bravo! @EuroInterventio @PCRonline #EuroPCR @mirvatalasnag @KardiologieHH @IndahSP_MD @ABeneduceMD @guilbon @Hragy @IainGil @c_luqueno @MiChen__

🎥In this interview, @valeriaparadies and @kiadeb87 discuss the new expert consensus document on sex-specific risks, tailored antithrombotic strategies, and improving female representation in ACS trials published in EuroIntervention with the #EAPCI and the @escardio working group…

We are almost at the end of #EuroPCR but there is still Friday to come - enjoy your evening and see you tomorrow!

AsiaIntervention held its 2025 Strategic Board Meeting at EuroPCR in Paris with Editor-in-Chief Upendra Kaul and Deputy Editors. Grateful for their inspiring leadership. #EuroPCR #interventionalcardiology